Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]

Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]

Korol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315–1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowl...

Full description

Bibliographic Details
Main Authors:	Korol AR, Zborovska O, Kustryn T, Dorokhova O, Pasyechnikova N
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-08-01
Series:	Clinical Ophthalmology
Online Access:	https://www.dovepress.com/corrigendum-intravitreal-aflibercept-for-choroidal-neovasculariza-peer-reviewed-article-OPTH

Similar Items

A customized regimen of intravitreal aflibercept for the treatment of choroidal neovascularization secondary to different chorioretinal diseases
by: Magdy Moussa, et al.
Published: (2023-01-01)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
by: Shih-Lin Chen, et al.
Published: (2021-09-01)

Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks
by: Ebru Esen, et al.
Published: (2015-01-01)

Presumed Melanocytoma-Associated Choroidal Neovascular Membrane with Hemorrhage Successfully Treated with Intravitreal Aflibercept Injections
by: Austin S. Yu, et al.
Published: (2023-09-01)

Chorioretinal response to intravitreal aflibercept injection in acute central serous chorioretinopathy
by: Byung Ju Jung, et al.
Published: (2019-12-01)

Comparison of morphometric changes in the chorioretinal complex after anti-VEGF treatment in patients with pathologic myopia versus those with neovascular age-related macular degeneration
by: O.M. Blavatska, et al.
Published: (2018-02-01)

Intravitreal Aflibercept as an Adjunct to Systemic Therapy in a Case of Choroidal Neovascular Membrane Associated with Sympathetic Ophthalmia
by: Ali Osman Saatçi, et al.
Published: (2018-08-01)

CHOROIDAL NEOVASCULARIZATION IN A CASE OF CHORIORETINAL COLOBOMA TREATED WITH INTRAVITREAL ANTI-VEGF INJECTONS: A CASE REPORT
by: Dicky Budiman Simanjuntak, et al.
Published: (2022-09-01)

Chorioretinal coloboma complications: retinal detachment and choroidal neovascular membrane
by: Rehan M Hussain, et al.
Published: (2017-01-01)

Choroidal structural changes determined by the binarization method after intravitreal aflibercept treatment in neovascular age-related macular degeneration
by: Emine Temel, et al.
Published: (2021-08-01)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
by: Ellabban AA, et al.
Published: (2012-05-01)

Concurrent tuberculous chorioretinitis with choroidal neovascularization and tuberculous meningitis: a case report
by: Yan-Kun Zhang, et al.
Published: (2020-06-01)

Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
by: Rush RB, et al.
Published: (2022-12-01)

Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization
by: Farhad Fazel Najafabadi, et al.
Published: (2015-01-01)

Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma
by: Kubota-Taniai M, et al.
Published: (2011-07-01)

Intravitreal Conbercept or Ranibizumab for myopic choroidal neovascularization
by: Cai-Yun Zhang, et al.
Published: (2022-06-01)

Intravitreal injection of ziv-aflibercept in the treatment of choroidal and retinal vascular diseases
by: Kamran HodjatJalali, et al.
Published: (2017-09-01)

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
by: Miura M, et al.
Published: (2013-08-01)

Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy
by: Arakawa A, et al.
Published: (2017-04-01)

Intravitreal bevacizumab in choroidal neovascularization associated with Best′s vitelliform dystrophy
by: Subrata Mandal, et al.
Published: (2011-01-01)

Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta
by: Pukhraj Rishi, et al.
Published: (2012-01-01)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
by: Shanmugam Mahesh, et al.
Published: (2007-01-01)

Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathy.
by: Shotaro Asano, et al.
Published: (2018-01-01)

Favorable clinical outcome with intravitreal aflibercept treatment in a case with bilateral choroidal neovascular membrane and quiescent Vogt-Koyanagi-Harada syndrome
by: Ipek, Sefik Can, et al.
Published: (2020-04-01)

Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
by: Ashwin Gupta, et al.
Published: (2022-01-01)

Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01)

Two-Year Outcome of Aflibercept for the Treatment of Choroidal Neovascularization in Punctate Inner Choroidopathy
by: Luis Arrevola, et al.
Published: (2019-01-01)

Clinical course of choroidal neovascular membrane in West Nile virus chorioretinitis: a case report
by: Roberta Zito, et al.
Published: (2021-04-01)

Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma
by: Yoshikawa T, et al.
Published: (2015-03-01)

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
by: Yasmin Ali Said, et al.
Published: (2022-04-01)

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
by: T. Barth, et al.
Published: (2019-11-01)

Subfoveal Choroidal Thickness and Treatment Outcomes of Intravitreal Aflibercept for Branch Retinal Vein Occlusion
by: Yoshihito Sakanishi, et al.
Published: (2021-06-01)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Short-Term Efficacy in Polypoidal Choroidal Vasculopathy Patients Treated With Intravitreal Aflibercept or Conbercept
by: Yin Xue, et al.
Published: (2022-02-01)

Bietti crystalline dystrophy complicated by choroidal neovascularization treated with a single dose of aflibercept
by: Merve Ozbek, et al.
Published: (2023-01-01)

Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.
by: Jeong Hun Bae, et al.
Published: (2017-01-01)

Intravitreal Conbercept therapy for choroidal neovascularization due to high myopia
by: Yan-Jie Xie, et al.
Published: (2018-02-01)

Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
by: Sachdev Nishant, et al.
Published: (2007-01-01)

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Secondary to Endogenous Endophthalmitis
by: Shwu-Jiuan Sheu
Published: (2009-11-01)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
by: Neeraj Pandey, et al.
Published: (2013-01-01)